Contacts
Address
India, Gujarat, Ahmedabad, 380009, Chinubhai Centre, Off. Nehru Bridge, Ashram Road
Phones of enterprise
management
+91
When placing an order please inform the manager that you've learned the information on Allbiz! Thank you that you buy on Allbiz!
+91
When placing an order please inform the manager that you've learned the information on Allbiz! Thank you that you buy on Allbiz!
Internet
Site:
About enterprise
Intas Pharmaceuticals, Ltd.
Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India.
Intas's success and incessant growth lies in clinical execution of successful and strategic moves made in the areas of manufacturing, R & D, Biotechnology and global operations over three decades. Today, Intas is a $350 million organization with overall 35% CAGR growth over the last 4 years and is ranked as the 11th largest pharmaceutical company in the domestic market. (as per IMS Health India, Secondary Stockist Audit (SSA), June 2011)
In the domestic market, Intas is one of the leading players in chronic therapy areas, also having presence in central nervous system (CNS), cardiovascular system (CVS), diabetology, gastroenterology and pain management. Recently, Intas has extended its presence into other therapy areas such as gynecology, infertility and respiratory care.
Besides growing domestic dominance, Intas is also present in over 50 countries worldwide and has made successful forays into contract manufacturing and contract marketing tie-ups across the world predominantly in North America, Europe & Latin America.
Intas's global strategy includes alliances with leading Global Pharma Companies for development and distribution of products as well as direct product distribution.
Its subsidiary, Intas Biopharmaceuticals Limited, has made substantial investments in the development, manufacturing and marketing of products based on biotechnology (biosimilars) in chronic therapy areas including oncology and nephrology.
Continual R & D initiatives have strengthened niche and complex product offerings in India and International markets. Commercialized in India, three pharmaceutical formulations are based on the novel lipid based drug delivery system with studies ongoing to extend these products to International markets.
Intas has made strategic investments in ten manufacturing facilities, globally. Between them, these facilities have received approvals from various prominent international regulatory bodies, including U.S. Food and Drug Administration (FDA).
In stock
Brand Name
Active Ingredient(s)
Therapeutic Segment
Pack Details
...
Group: Oncology Products
In stock
Brand Name
Active Ingredient(s)
Therapeutic Segment
Pack Details
...
Group: Veterinary medication
In stock
Brand Name
Active Ingredient(s)
Therapeutic Segment
Pack Details
...
Group: Veterinary medication
In stock
Brand Name
Active Ingredient(s)
Therapeutic Segment
Pack Details
...
Group: Hematologic means, others
In stock
Brand Name
Active Ingredient(s)
Therapeutic Segment
Pack Details
...
Group: Cardiovascular preparations
In stock
Brand Nam
Active Ingredient(s)
Therapeutic Segment
Pack Details
...
Group: Antibacterial Drugs
In stock
Brand Name
Active Ingredient(s)
Therapeutic Segment
Pack Details
...
Group: Antidepressants
In stock
Brand Name
Active Ingredient(s)
Therapeutic Segment
Pack Details
...
Group: Antihistaminic preparations